Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Laura Dumitrescu, Cris S. Constantinescu & Radu Tanasescu. (2018) Recent developments in interferon-based therapies for multiple sclerosis. Expert Opinion on Biological Therapy 18:6, pages 665-680.
Read now
Read now
Kendra L Furber, Marina Van Agten, Charity Evans, Azita Haddadi, J Ronald Doucette & Adil J Nazarali. (2017) Advances in the treatment of relapsing–remitting multiple sclerosis: the role of pegylated interferon β-1a. Degenerative Neurological and Neuromuscular Disease 7, pages 47-60.
Read now
Read now
Eleonora Cocco & Maria Giovanna Marrosu. (2015) Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis. Therapeutics and Clinical Risk Management 11, pages 759-766.
Read now
Read now
Aaron E Miller. (2015) Teriflunomide for the treatment of relapsing–remitting multiple sclerosis. Expert Review of Clinical Immunology 11:2, pages 181-194.
Read now
Read now
François Curtin & Hans-Peter Hartung. (2014) Novel therapeutic options for multiple sclerosis. Expert Review of Clinical Pharmacology 7:1, pages 91-104.
Read now
Read now
Articles from other publishers (9)
A.N. Boyko, K.Z. Bakhtiyarova, O.V. Boyko, V.A. Dudin, L.G. Zaslavskii, N.A. Malkova, E.V. Parshina, I.Ye. Poverennova, S.A. Sivertseva, N.A. Totolyan, S.G. Shchur, F.A. Khabirov, Z.A. Goncharova, M.N. Zakharova, D.D. Bolsun, A.V. Zinkina-Orikhan, Yu.N. Lin’kova, T.V. Chernovskaya & A.A. Porozova. (2023) Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 123:2, pages 52.
Crossref
Crossref
A. N. Boyko. (2022) Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a). Neurology, Neuropsychiatry, Psychosomatics 14:1S, pages 34-37.
Crossref
Crossref
N.N. Spirin, Ya.V. Vlasov, M.N. Zakharova, N.V. Khachanova, E.V. Popova, F.A. Khabirov, N.A. Totolyan, S.A. Sivertseva, Z.A. Goncharova, L.L. Korsunskaya, T.I. Yakushina, O.V. Matvievskaya, T.O. Simaniv & A.N. Boyko. (2022) New opportunities in the treatment of patients with multiple sclerosis (Resolution of the Council of Experts on April 23, 2022, Moscow, JSC «BIOCAD»). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 122:7, pages 84.
Crossref
Crossref
A.N. Boyko, O.V. Boyko, K.Z. Bakhtiyarova, E.I. Gusev, V.A. Dudin, L.G. Zaslavsky, N.A. Malkova, Ye.V. Parshina, I.Ye. Poverennova, S.A. Siverceva, N.A. Totolyan, S.G. Shchur, A.S. Fedulov, F.A. Khabirov, D.D. Bolsun, A.V. Zinkina-Orikhan, Yu.N. Linkova & T.V. Chernovskaya. (2022) Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 122:1, pages 62.
Crossref
Crossref
Domenico Nuzzo & Pasquale Picone. (2021) Multiple Sclerosis: Focus on Extracellular and Artificial Vesicles, Nanoparticles as Potential Therapeutic Approaches. International Journal of Molecular Sciences 22:16, pages 8866.
Crossref
Crossref
A. Dicitore, E. S. Grassi, M. O. Borghi, G. Gelmini, M. C. Cantone, G. Gaudenzi, L. Persani, M. Caraglia & G. Vitale. (2017) Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation. Journal of Endocrinological Investigation 40:7, pages 761-770.
Crossref
Crossref
Reina Sasaki. (2015) Natural interferon-beta treatment for patients with chronic hepatitis C in Japan. World Journal of Hepatology 7:8, pages 1125.
Crossref
Crossref
Daniel Harari, Nadine Kuhn, Renne Abramovich, Keren Sasson, Alla L. Zozulya, Paul Smith, Martin Schlapschy, Rina Aharoni, Mario Köster, Raya Eilam, Arne Skerra & Gideon Schreiber. (2014) Enhanced in Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis. Journal of Biological Chemistry 289:42, pages 29014-29029.
Crossref
Crossref
Shien Guo, Christopher Pelligra, Catherine Saint-Laurent Thibault, Luis Hernandez & Anuraag Kansal. (2014) Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches. PharmacoEconomics 32:6, pages 559-572.
Crossref
Crossref